loading

Intensity Therapeutics Inc Azioni (INTS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
20.30%
2.705
3.394 3.203 3.57 5.069
Operating Income/Loss
20.30%
-2.705
-3.394 -3.203 -3.57 -5.069
Income/Loss From Continuing Operations Before Tax
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Income/Loss From Continuing Operations After Tax
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Net Income/Loss
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
24.35%
18.87
15.17 0.1646 13.80 13.71
Diluted Average Shares
24.35%
18.87
15.17 0.1646 13.80 13.71
Basic Earnings Per Share
40.91%
-0.13
-0.22 -0.22 -0.25 -0.36
Diluted Earnings Per Share
40.91%
-0.13
-0.22 -0.22 -0.25 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):